High-Throughput Camelid Antibody Generation for Broad Epitope Coverage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibody technologies struggle to systematically target functional epitopes of disease targets due to inadequate coverage of epitopes and redundant selection, resulting in low successful rates.

Innovation Solution

A high-throughput method is developed to generate camelid antibodies by enriching and proliferating antigen-specific B-cells from immunized camelids, generating NGS libraries of VHH2, VHH3, and VH1 sequences, grouping these sequences by lineages, ranking them based on priority factors, and selecting representative sequences to ensure broad epitope coverage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current antibody technologies generate binders randomly and sporadically, then the process is simple, but the coverage of epitopes is inadequate and the successful rate is low

Engineering Contradiction:
Improvesuccessful rateVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-enriching and proliferating B-cells from immunized camelids before generating the antibody library. This preparatory step ensures that the subsequent NGS library generation starts with a pre-selected population of antigen-specific B-cells, thereby improving epitope coverage and successful rate while maintaining reasonable process complexity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements feedback through the systematic grouping of sequences by lineages and ranking by priority factors. This structured approach uses information from sequence analysis to guide the selection process, creating a feedback loop that improves epitope coverage by systematically identifying and prioritizing diverse antibody lineages rather than relying on random selection

Inventive Principle:
Principle #23Feedback

2Adaptability or versatility

If current antibody technologies use random selection approaches, then the method is straightforward, but there is redundant selection and inadequate epitope coverage

Engineering Contradiction:
Improveepitope coverageVSAvoidmethod complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the antibody library into distinct lineages based on sequence grouping. This segmentation allows for systematic analysis and selection of diverse epitope-specific lineages, improving adaptability and epitope coverage by ensuring representation from multiple antibody lineages rather than random selection

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses parameter changes by ranking lineages based on multiple priority factors including sequence diversity, binding affinity, and epitope specificity. This multi-parameter approach systematically optimizes epitope coverage by selecting lineages that meet multiple criteria rather than relying on simple random selection

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If hundreds or thousands of diverse antibodies are generated to cover broad epitopes, then the epitope coverage is comprehensive, but the time and resources required increase

Engineering Contradiction:
Improveepitope coverageVSAvoiddevelopment time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The patent reduces development time by performing preliminary enrichment and proliferation of B-cells before library generation. This pre-selection step concentrates antigen-specific B-cells, allowing for more efficient library generation and faster identification of diverse epitope-specific antibodies compared to generating libraries from未经筛选的B-cell populations

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent replaces traditional mechanical screening methods with NGS-based sequence analysis and bioinformatics. This substitution allows for parallel processing of thousands of sequences through computational grouping and ranking, dramatically reducing the time required to identify diverse epitope-specific antibodies compared to sequential experimental screening

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS12442106B2Sequence-based high throughput method generating camelids antibodies to cover broad epitopes with high-resolution
Publication Date: 2025.10.14 ZHEJIANG NANOMAB TECH CENT CO LTD
  • US12442106B2 patent drawing
  • US12442106B2 patent drawing
  • US12442106B2 patent drawing

AI summary

A method for generating a plurality of diverse camelid antibodies to cover functional epitopes of the target with high-resolution. Also provided is a method for generating camelid antibodies.